Zydus Cadila gets USFDA’s nod for Mirtazapine Orally Disintegrating Tablets

05 Jun 2017 Evaluate

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Mirtazapine Orally Disintegrating Tablets USP in strengths of 15 mg, 30 mg & 45 mg. The drug is an anti-depressant and will be produced at the group's formula ions manufacturing facility at Baddi.

The group now has more than 115 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×